Edikan Archibong Ogunnaike

Edikan joined UNC in 2018. She received her B.S. and M.S. in Chemistry from Florida A& M University, and her Ph.D. at the University of South Florida from the Department of Chemical and Biomedical Engineering. Her recent focus has been to translate nanobiotechnology into cancer immunotherapy delivery systems in solid tumors. Joining Dr. Kabanov’s lab, her goal is to explore non-lipid-based delivery systems and cellular mediated systems to enhance mRNA delivery to further advance vaccination technology.

Edikan’s Publications